1

靶向炎症微环境核心通路逆转肿瘤恶性进展的机制与应用研究

自然科学奖

1、 陈虹锦，副教授，贵州医科大学

2、 宋颖楠，副教授，贵州医科大学

3、 陈雄，主任医师，温州医科大学附属第一医院

4、 杨栋梁，副教授，南京工业大学

1、 贵州医科大学

2、 温州医科大学附属第一医院

3、 南京工业大学

1、Curcumin derivative C66   suppresses pancreatic cancer progression through the inhibition of   JNK-mediated inflammation. Molecules. 2022;27(10):3076, Hongjin Chen, Yuchen   Jiang, Rongdiao Liu, Jie Deng, Qinbo Chen, Lingfeng Chen, Guang Liang, Xiong   Chen^* and Zheng Xu^*

2、Centromere protein F   promotes progression of hepatocellular carcinoma through ERK and cell   cycle-associated pathways. Cancer gene therapy. 2022 Jul;29(7):1033-42, Hongjin   Chen, Fubing Wu, Haojun Xu, Guanqun Wei, Min Ding, Fanggui Xu, Amudha   Deivasigamani, Guoren Zhou*, Kam M Hui*, Hongping Xia*.

3、 Multifaceted roles of   copper ions in anticancer nanomedicine. Advanced healthcare materials.   2023;12(23):2300410, Siyuan Yang, Yingnan Song（共同一作）, Yanling Hu*, HongJin   Chen, Dongliang Yang*, Xuejiao Song*.

4、An NIR-II responsive   nanoplatform for cancer photothermal and oxidative stress therapy. Frontiers   in Bioengineering and Biotechnology. 2021, 15;9:751757. Bin Huang, Yuanpeng   Huang, Han Han, Qiuyue Ge, Dongliang Yang*, Yanling Hu 3, Meng Ding*, Yanqing   Su 5, Yanbin He, Jinjun Shao, Jianfeng Chu *

5、Acute or chronic   inflammation role in gastrointestinal oncology, World Journal of   Gastrointestinal Oncology, 2022 Aug 15;14(8):1600-1603. Hong-Jin   Chen，Gui-You   Liang，Xiong   Chen，Zhou   Du*